Evidence map›Paper›PMID 27510797›Full record

ArticleJournal of tissue engineering and regenerative medicine2016

Chemical modification of extracellular matrix by cold atmospheric plasma-generated reactive species affects chondrogenesis and bone formation.

Peter Eisenhauer, Natalie Chernets, You Song, Danil Dobrynin, Nancy Pleshko, Marla J Steinbeck, Theresa A Freeman

Open access · greenAbstract read
In one paragraph

Article in Journal of tissue engineering and regenerative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. ROS from Physical Plasmas: Redox Chemistry for Biomedical Therapy.Oxidative medicine and cellular longevity · 2019
    Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Peter EisenhauerDepartment of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
Natalie ChernetsDepartment of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
You SongDepartment of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
Danil DobryninDrexel Plasma Institute, Drexel University, Philadelphia, PA, USA.
Nancy PleshkoDepartment of Bioengineering, Temple University, Philadelphia, PA, USA.
Marla J SteinbeckSchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA.
Theresa A FreemanDepartment of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA, USA. theresa.freeman@jefferson.edu.
Drexel University · USThomas Jefferson University · USTemple University · US

Funding

Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell ActivationR01EB013011 · NIBIB · THOMAS JEFFERSON UNIVERSITY · PI FREEMAN, THERESA A · 2011 to 2014
$1.4M
NIBIB NIH HHS R01 EB013011
6 · The paper itself

Abstract

The goal of this study was to investigate whether cold plasma generated by dielectric barrier discharge (DBD) modifies extracellular matrices (ECM) to influence chondrogenesis and endochondral ossification. Replacement of cartilage by bone during endochondral ossification is essential in fetal skeletal development, bone growth and fracture healing. Regulation of this process by the ECM occurs through matrix remodelling, involving a variety of cell attachment molecules and growth factors, which influence cell morphology and protein expression. The commercially available ECM, Matrigel, was treated with microsecond or nanosecond pulsed (μsp or nsp, respectively) DBD frequencies conditions at the equivalent frequencies (1 kHz) or power (~1 W). Recombinant human bone morphogenetic protein-2 was added and the mixture subcutaneously injected into mice to simulate ectopic endochondral ossification. Two weeks later, the masses were extracted and analysed by microcomputed tomography. A significant increase in bone formation was observed in Matrigel treated with μsp DBD compared with control, while a significant decrease in bone formation was observed for both nsp treatments. Histological and immunohistochemical analysis showed Matrigel treated with μsp plasma increased the number of invading cells, the amount of vascular endothelial growth factor and chondrogenesis while the opposite was true for Matrigel treated with nsp plasma. In support of the in vivo Matrigel study, 10 T1/2 cells cultured in vitro on μsp DBD-treated type I collagen showed increased expression of adhesion proteins and activation of survival pathways, which decreased with nsp plasma treatments. These results indicate DBD modification of ECM can influence cellular behaviours to accelerate or inhibit chondrogenesis and endochondral ossification. Copyright © 2016 John Wiley & Sons, Ltd.

Indexed as

ChondrogenesisOsteogenesisAnimalsBone Morphogenetic Protein 2Extracellular MatrixHumansMicePlasma GasesReactive Oxygen SpeciesRecombinant ProteinsBMP2 protein, humanBone Morphogenetic Protein 2Plasma GasesReactive Oxygen SpeciesRecombinant Proteinsbonechondrogenesisendochondral ossificationFTIRmatrigelplasma

Identifiers

PMID27510797
PMCPMC5683170
OpenAlexW2513838822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.